Early, targeted treatment improves the outcome of rheumatoid arthritis, reducing disease-associated disability and mortality. Until now, it was unknown whether these beneficial effects extended beyond 10 years following initial therapy. Could these effects persist even after 20 years?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis
European Radiology Open Access 26 April 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann. Rheum. Dis. 76, 960–977 (2017).
Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637 (2010).
Cush, J. J. Early rheumatoid arthritis — is there a window of opportunity? J. Rheumatol. Suppl. 80, 1–7 (2007).
Daien, C. I., Hua, C., Combe, B. & Landewe, R. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open 3, e000404 (2017).
Gwinnutt, J. M. et al. The 20 year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results from the Norfolk Arthritis register. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.40090 (2017).
O'Dell, J. R. in Kelley's Textbook of Rheumatology 9th edn Ch. 71 1137–1160 (Elsevier Saunders, 2013).
Mian, A. N. et al. Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies. BMC Musculoskelet. Disord. 17, 44 (2016).
Andersson, M. L., Forslind, K. & Hafström, I. Patients with early rheumatoid arthritis in the 2000s have equal disability and pain despite less disease activity compared with the 1990s: data from the BARFOT Study over 8 years. J. Rheumatol. 44, 723–731 (2017).
Myasoedova, E. et al. Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA? J. Rheumatol. 44, 732–739 (2017).
Kiadaliri, A. A., Felson, D. T., Neogi, T. & Englund, M. Rheumatoid arthritis as underlying cause of death in 31 countries, 1987-2011: trend analysis of WHO mortality database. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.40091 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zink, A., Albrecht, K. The benefits of early treatment after decades. Nat Rev Rheumatol 13, 458–459 (2017). https://doi.org/10.1038/nrrheum.2017.104
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2017.104
This article is cited by
-
Oral health–related quality of life among individuals with rheumatoid arthritis
Clinical Rheumatology (2019)
-
Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis
European Radiology (2019)